Multiple broad cellular pathways

The designation Multiple broad cellular pathways does not refer to a specific, identifiable molecular target such as a receptor, enzyme, or ion channel. Instead, it serves as a generalized descriptor for the systemic or pleiotropic effects observed with certain pharmacological agents that influence a wide array of biological processes simultaneously, such as metabolism, signal transduction, and gene expression (IUPHAR/BPS Guide to Pharmacology). In drug discovery, a therapeutic target must be a discrete biological entity that can be specifically modulated; therefore, a collection of pathways lacks the necessary specificity for structure-based drug design or precise mechanism-of-action studies. This term is frequently encountered when describing the complex, multi-faceted impact of drugs like metformin or corticosteroids, which do not act on a single target but rather shift the state of various cellular networks (PubMed: 30573434). Because it encompasses too much information and lacks a singular molecular identity, it is considered an incorrect entry for a target-specific database. Analysts should seek to identify the specific proteins or genes within these pathways that are the primary drivers of the observed therapeutic effect.

Not applicable